Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease
{{output}}
Emerging evidence suggests the gut microbiome's potential in predicting response to biologic treatments in patients with inflammatory bowel disease (IBD). In this prospective study, we aimed to predict treatment response to vedolizumab and ustekinumab, integra... ...
